The UK government’s recently unveiled life sciences sector plan has faced sharp criticism from industry leaders for failing to address key concerns about investment in innovative medicines. The 78-page strategy,
The UK government’s recently unveiled life sciences sector plan has faced sharp criticism from industry leaders for failing to address key concerns about investment in innovative medicines. The 78-page strategy,






